Following impressive results using OEM pumps from Watson-Marlow Pumps Group on an automated batch cell culture system, a Hertfordshire-based company specialising in automated life science applications has now adopted the pumps on additional products – with equal success.
Roche and Hamilton Robotics jointly announced the introduction of a new, integrated platform enabling automated DNA sample enrichment for Roche’s 454 GS Junior sequencer.
The platform builds on the integration of Roche’s REM e System with Hamilton’s Microlab® NIMBUS NGS workstation, resulting in reduced hands-on time, minimized operational variability and more consistent results. “This new integrated platform will replace about four hours of laborious manual work,” said Thomas Schinecker, head of 454 Life Sciences “It is a true walkaway solution, offering an economical, convenient, compact enrichment procedure for all our GS Junior customers. We look forward to continuing our collaboration with Hamilton to develop more innovative, automated solutions for our GS Junior System.”....
It is common knowledge that pipetting regularly increases the risk of developing Repetitive Strain Injuries (RSI’s). By applying Good Pipetting Practice within your lab you can help to prevent these risks.
One way that is suggested to help reduce the repetition of pipetting and the risk of RSI is to simply take frequent breaks every 20 or 30 minutes to stretch your shoulders, arms and hands. As part of Anachem’s GPP programme they are offering a free Stretch Poster, which shows diagrams with instructions of the different ways you can stretch to ensure that you shake off the stiffness and stress that accumulates after long hours at the lab bench....
Centre Dedicated to Diagnosis and Treatment Derived from Single-Cell Exploration
Government officials, academic, and industry leaders gathered to celebrate the official opening of the Single-Cell Omics Centre (SCOC) in Singapore on April 12, 2013. It is the first research centre in Asia exclusively dedicated to accelerating the understanding of how individual cells work, and how diagnosis and treatment might be enhanced through insight derived from single cells....
Read MoreUniversity of Glasgow receives funding for world-leading stratified medicine Innovation CentreApr 29, 2013
The University of Glasgow is set to boost its contribution to global medical research and the Scottish economy following the announcement of funding to build a major research centre.
The Scottish Funding Council is providing £8m over five years to back the creation of the £20m Stratified Medicine Scotland Innovation Centre (SMS-IC) at the new South Glasgow Hospitals Campus. The SMS-IC will also involve a consortium of other universities, NHS Scotland, and industry partners. Construction work is expected to begin in November this year, with a fully-operational centre due to open in September 2015....
BioCity CEO to deliver key address at BioScotland on 30th April
Scottish ambitions to double the life sciences sector by 2020 could be realised if the ‘perfect storm’ of prevailing conditions are grasped and built on, according to CEO of the BioCity Group Dr Glenn Crocker. Commenting ahead of his address to the gathering of sector experts at BioScotland on 30 April, Dr Crocker identifies several factors working together to have a profound impact on the long term future of the life sciences sector in Scotland....
Materials and biophysical characterization company Malvern Instruments Ltd and NETZSCH Grinding & Dispersing a worldwide manufacturer of industrial wet and dry grinding, mixing, dispersing and kneading equipment, have entered into a cooperative marketing agreement.
Both organizations serve a broad range of market sectors from pharmaceuticals, ceramics, nano-technology applications, food and surface coatings through to mining metals and minerals. The global agreement, initially in place for three years, will harness the strength of each company’s world-leading brands and unique expertise in materials processing and materials characterization. Under the terms of the agreement NETZSCH will standardize on Malvern’s particle sizing and characterization equipment, primarily the Mastersizer 3000 laser diffraction particle size analyzer...
Cambio now supplies UK life scientists with the new Globin-Zero™ Gold Kit from Epicentre. This innovative product is used to clean up excess globin mRNA and rRNA in total blood RNA samples, allowing improved identification and sequencing of the target RNA components
Globin-Zero™ Gold Kits efficiently remove abundant globin RNAs from both intact and degraded human, mouse and rat total blood RNA samples. In these samples, as much as 70% of the mRNA can be globin mRNA, and this would account for a large majority of sequencing reads in RNA-Seq experiments. By removing excess RNA, the Globin-Zero™ Gold Kit enables deeper sequencing into blood RNA samples and improved identification of less abundant RNA types, including viral RNA. Complete in just 90 minutes, the rapid, single-pass process saves time and reduces sample waste compared to common multi-step procedures, which require the use of various kits to complete the same task....
Creative Biogene has announced a rapid and cost-effective stable cell line service for cellular function assays, trafficking, protein production, target validation, and other research purposes using an innovative and unique platform that allows one to go from gene to stable cell line
The service includes commercial and research cell line based on its proprietary expression vector, for example, ″Lenti-Stable″ (stable cell line using lentivector) and ″Select-Stable″ (stable cell line using selection system) , high throughput cell screening technologies and serum, animal components free process without any adaptation issue in a significantly reduced timeline....
Read MoreMicrosaic Systems Signs Commercial Agreement for Novel Miniaturised Chip-based Scientific InstrumentApr 25, 2013
Microsaic Systems plc (AIM: MSYS), the high technology company developing next generation mass spectrometry instruments, is pleased to announce the signing of a second major agreement to provide its miniature mass spectrometer - the Microsaic 4000 MiD® - as an Original Equipment Manufacturer (OEM).
The agreement is for the global, non-exclusive marketing and sale of the 4000 MiD® as a stand-alone instrument for use in specified applications. The terms of the agreement include commitments to minimum quantities during an initial period of 42 months. Shipments under the agreement are anticipated to commence in Q3 2013....
SELECTBIO is delighted to announce that the European Lab Automation (ELA) 2013 Conference and Tradeshow will open its doors from 6 June
A two day, five conference track congress, the event offers over 75 presentations on automation and its application within life science, alongside an exhibition from leading equipments vendors and supporting companies. ELA provides life science researchers and professionals with an unparalleled opportunity to encourage technological discussions and scientific collaboration....
Biopharma Process Systems (BPS) is pleased to be representing Avestin Liposome Extruders and High Pressure Homogenisers within the UK and Ireland
Avestin is the leading manufacturer of high pressure homogenizers suitable for high-pressure applications such as pharmaceuticals and biotechnology. Founded in 1991, Avestin’s focus on quality of engineering and design led to the development of a unique design that eliminates all o-rings and gaskets in the product path. This means less risk of contamination, easier cleaning and no risk of leakage. All face seals are precision-machined metal-to-metal or metal-to-ceramic for optimal durability and efficiency....
Read MoreNovasep discovers explosive properties of Togni reagent IIApr 23, 2013
Novasep reclassifies reagent and informs market about new safety measures required
Novasep, a leading supplier of purification and global manufacturing solutions of synthetic molecules and biomolecules, today announces its R&D team has discovered and characterised the explosive properties of the Togni reagent II and intermediates at the Novasep Leverkusen site in Germany. The findings have been published in the March edition of the journal Organic Process Research and Development....
Read MoreApr 22, 2013
A two day symposium focussing on today’s challenges to Separation Science posed by Complex Matrices to be held at the Bat Research Labs on 22nd & 23rd May 2013
Chromatographic and mass spectrometric analysis in vegetable matter, smoke aerosols, particulates and products of combustion will be explored by specialists from a variety of industries. An exhibition of analytical instrumentation by leading manufacturers will also form an important element of the symposium....
Metrohm and FOSS have entered into a strategic alliance strengthening the two companies’ leading positions in their respective markets
In this alliance, we, Metrohm, will become the sole global distributor of FOSS NIR instruments for the chemical, petrochemical, pharmaceutical, and environmental sectors. In a nutshell, FOSS NIRSystems will become Metrohm NIRSystems. Metrohm has been known for top-quality solutions for wet chemical analysis for more than 60 years. Now, we are taking a step beyond, bringing to you the finest solutions for NIR Spectroscopy. Our enlarged portfolio gives you even more options to choose and find the perfect solution for your analytical requirements...
Analytik Jena AG, based in Jena, Germany has acquired all of the outstanding shares of Upland, California based UVP, LLC including its subsidiary, Ultra-Violet Products, Ltd., located in Cambridge UK.
UVP is a leading manufacturer of bioimaging systems for applications in proteomics, genomics, plant and animal sciences. The company also manufactures ultraviolet products, light sources, and laboratory equipment such as hybridization ovens, transilluminators, crosslinkers and PCR hoods....
Structural Proteomics Laboratory Directed by Prof. Dr. Amit Kumar Mandal Recognized for Global Disease Research
At a ceremony at St. John’s Research Institute (Bangalore, India) Waters announced the selection of the St. John’s Research Institute for its Centers of Innovation Program for research in the field of structural proteomics. It is the first institution in India to receive the designation of a Waters® Center of Innovation. Under the direction of Prof. Dr. Amit Kumar Mandal, a Professor of Molecular Medicine and Clinical Proteomics, St. John’s has earned a reputation for its research in blood disorders and other diseases that disproportionately affect disadvantaged populations...
The German Society for Cell Biology (DGZ) in Heidelberg has recognized outstanding research in the field of basic cell biology this year with the BINDER Innovation Prize with a 4,000 Euro endowment
Among the many scientific papers, the work from Dr. Stephan Grill of the Max Planck Institute for Physics of Complex Systems (MPI-PKS) and Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBF) in Dresden, Germany stood above the rest. The scientist impressed the independent jury with his article on the interaction of mechanical and biochemical signals for the biological process of cell polarization....
Valid until 30 June 2013, Eppendorf’s latest Advantage promotion delivers considerable savings on a variety of product bundles, offering researchers the chance to try products from this leading brand for the first time at a lower than usual investment, or to stock up on valued consumables and equipment
Purchasers can make savings of up to 20% on Eppendorf Combitips® advanced/Multipette® bundles, as well as taking advantage of offers on the Eppendorf µCuvette™ G1.0 and BioSpectrometers.Supporting serial pipetting together with the Eppendorf Multipette®, Eppendorf Combitips advanced are available in a range of purity grades to support work across all life science laboratories, whatever the application....
Thermo Fisher Scientific and Life Technologies Corporation, a leading life sciences company, have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as of year end 2012)
The transaction, which was approved by both companies’ boards of directors, will create an unrivaled leader in serving research, specialty diagnostics and applied markets. The combination builds on both companies’ technological strengths to accelerate results for life sciences customers working in proteomics, genomics and cell biology...
New services to provide early go/no go data decisions to reduce drug discovery costs
Cellectricon, a leading provider of advanced cell-based screening technologies, today announced the launch of its Discovery Services division. The new services offer pharma/biotech companies and CROs cutting-edge phenotypic screening support, accelerating drug discovery and cell-based assay research into cytoskeletal disturbances – especially for chronic pain...